Andrew Thomas

Entrepreneur

📍 Zurich, Switzerland🔄 Updated September 2026💼 7 investments📅 10 years investing🗓 Last invested Mar 2021
VC🌍 Switzerland
7
Total investments
0
Early stage
0
Mid stage
5
Late stage
10y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
May 2020
SOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer and rare inherited disorders. The AI fueling our platform learns from the complex genomic and multimodal data provided by our community of users to create a collective intelligence over time. By using the power of data and AI, we are expanding access to data-driven medicine and enabling the patients of today to help the patients of tomorrow. Our science is driven by unrelenting passion for our mission to transform patient care by expanding access to data-driven medicine globally. We wouldn’t be able to achieve all that we have – and all that we will – without our people, who are driven by our shared purpose to ensure that every patient worldwide has equitable access to precision medicine. Our virtues are our behaviors we exhibit every day, and our mantra “We Care” is our driving force.
Board Observer
Apr 2020
Lunaphore Technologies S.A., a Bio-Techne brand, is a Swiss-based life sciences company founded in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. Community guidelines available here: https://link.lunaphore.com/guidelines
Board Observer
Sep 2019
Mecha-fluidic technology Founded in 2012, HYT is the first watch brand to use fluids to tell time. HYT's hybrid watches combine high-precision mechanical movements with mecha-fluidic technology. It uses two flexible bellows where liquid is stored and attached capillaries in which the liquid moves to indicate the time. This revolutionary system has been an integral part of the brand's DNA since its creation. Today HYT is an ecosystem that unites science, hi-technology, philosophy, art and design. Based in Neuchâtel, at the heart of the traditional Swiss watchmaking region, a dedicated team makes liquid time real time. Their radical wristwatches harmoniously incorporate a mechanical watch movement as the trigger to the fluid propulsion. They make total sense of time – time and time again.
Board Observer
Sep 2019
PRECIFLEX is a B2B innovation-driven company offering Ideation, R&D, Industrialization and Production of Custom-Made Microtechnical Systems, with a specialty in Liquids and Light systems. Since inception, PRECIFLEX is active in the Medical Devices industry supporting various projects for Ideation, R&D and Industrialization. Its unique know-how allows also PRECIFLEX to develop the luxury industry. Existing clients include the world's most desirable brands in the luxury industry.
Board Member
Feb 2019
SkyCell offers a data-driven container solution that allows pharma companies to optimise their supply chain by reducing, and even predicting, the risk of delivering sensitive drugs by air. It brings together big data, software and hardware to transform an ever-evolving supply chain, using a growing pool of nearly one billion data-points to enable a market-leading failure rate of less than 0.1%, whilst also reducing CO2 emissions by almost half. Founded in Switzerland in 2012, the company’s innovative approach has been validated by leading pharma companies and has partnerships with major airlines. For more information visit www.skycell.ch
Experience · 11 entries
All (11)
Investments (7)
Board (7)
2021
Board Observer
Mar 2021
CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDAs recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days. CeQur is headquartered in Horw, Switzerland. Please visit myceqursimplicity.com for more information.
2020
Board Observer
May 2020
SOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer and rare inherited disorders. The AI fueling our platform learns from the complex genomic and multimodal data provided by our community of users to create a collective intelligence over time. By using the power of data and AI, we are expanding access to data-driven medicine and enabling the patients of today to help the patients of tomorrow. Our science is driven by unrelenting passion for our mission to transform patient care by expanding access to data-driven medicine globally. We wouldn’t be able to achieve all that we have – and all that we will – without our people, who are driven by our shared purpose to ensure that every patient worldwide has equitable access to precision medicine. Our virtues are our behaviors we exhibit every day, and our mantra “We Care” is our driving force.
Board Observer
Apr 2020
Lunaphore Technologies S.A., a Bio-Techne brand, is a Swiss-based life sciences company founded in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. Community guidelines available here: https://link.lunaphore.com/guidelines
2019
Board Observer
Sep 2019
Mecha-fluidic technology Founded in 2012, HYT is the first watch brand to use fluids to tell time. HYT's hybrid watches combine high-precision mechanical movements with mecha-fluidic technology. It uses two flexible bellows where liquid is stored and attached capillaries in which the liquid moves to indicate the time. This revolutionary system has been an integral part of the brand's DNA since its creation. Today HYT is an ecosystem that unites science, hi-technology, philosophy, art and design. Based in Neuchâtel, at the heart of the traditional Swiss watchmaking region, a dedicated team makes liquid time real time. Their radical wristwatches harmoniously incorporate a mechanical watch movement as the trigger to the fluid propulsion. They make total sense of time – time and time again.
Board Observer
Sep 2019
PRECIFLEX is a B2B innovation-driven company offering Ideation, R&D, Industrialization and Production of Custom-Made Microtechnical Systems, with a specialty in Liquids and Light systems. Since inception, PRECIFLEX is active in the Medical Devices industry supporting various projects for Ideation, R&D and Industrialization. Its unique know-how allows also PRECIFLEX to develop the luxury industry. Existing clients include the world's most desirable brands in the luxury industry.
Show all 11 entries ↓
Investment activity
2016–2021 · 7 investments
20161201932020220211
Recent (last 2 years)Earlier